Li Jiang is a partner in our corporate transactions practice
Li's practice focuses on international capital markets and corporate transactions. She has extensive experience advising investment banks and corporates on Rule 144A and Regulation S securities offerings, including listings on the Hong Kong Stock Exchange, share placings and secondary offerings throughout Asia.
Li received her Juris Doctor degree, magna cum laude, from Washington University School of Law. She received her Master's degree in Economics from the University of Pennsylvania and Bachelor's degree in Economics & Finance from the University of Hong Kong.
Li is a native speaker of Mandarin and speaks fluent English and Cantonese.
Li is qualified in the state of New York and is admitted as a solicitor in Hong Kong.
Latest Insights
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
Legal development Are you ready? Upcoming changes to the Hong Kong Corporate Governance Code
05 Jun 2025
Discover more -
Legal development Seamless Transition: Hong Kong's New Company Re-domiciliation Regime
30 May 2025
Discover more -
Legal development Hong Kong Stock Exchange – new regime for treasury shares
19 Apr 2024
Discover more -
Legal development Hong Kong Stock Exchange puts climate-related disclosures in the spotlight
24 Apr 2023
Discover more -
Legal development New path for technology companies to list in Hong Kong
27 Mar 2023
Discover more -
Legal development Consultation on the Hong Kong Listing Rules relating to PRC issuers
02 Mar 2023
Discover more -
Legal development Hong Kong Stock Exchange - 2022 Analysis of ESG Practice Disclosure
02 Dec 2022
Discover more -
Legal development Revised rules for share schemes of HK listed companies
11 Aug 2022
Discover more -
Legal development Enhancements to the corporate governance code
16 Dec 2021
Discover more
Latest news, deals and awards
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
News Ashurst advises on China's biotech firm Cloudbreak Pharma’s Hong Kong IPO
03 Jul 2025
Discover more -
News Ashurst advises UBS on HK$400 million placing of new H shares by Shandong Boan Biotechnology
12 Jun 2025
Discover more -
News Ashurst advises on China's new generation sweetener manufacturer Newtrend Group's Hong Kong IPO
10 Jun 2025
Discover more -
News Ashurst represents Shanghai Voicecomm Information Technology in its Hong Kong IPO
18 Jul 2024
Discover more -
News Partner Li Jiang named 40 Under 40 by Asian Legal Business
21 Oct 2022
Discover more -
News Ashurst advises Chinese marketing service provider Rego Interactive
19 Oct 2022
Discover more -
News Ashurst receives four nominations from ALB Hong Kong Law Awards 2022
23 Aug 2022
Discover more -
News Ashurst advises Far East Consortium on the share acquisition of RF Properties Vauxhall Square
07 Apr 2022
Discover more -
News Ashurst advised on the share acquisition of Kai Tak multi-residential development site
07 Dec 2021
Discover more -
News Ashurst advising on Adriatic Metals proposed equity fundraise and secondary sale of shares
22 Nov 2021
Discover more -
News Ashurst advises Peel Hunt Limited on IPO
30 Sep 2021
Discover more -
News Ashurst appoints 14 new partners
30 Apr 2021
Discover more